Open-Label Extension Study of MHB018A in Subjects With Thyroid Eye Disease

NCT07262476 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

258

Enrollment

INDUSTRY

Sponsor class

Conditions

Thyroid Eye Disease (TED)

Interventions

DRUG: MHB018A injection

Sponsor

Minghui Pharmaceutical (Hangzhou) Ltd